Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05660577 · ClinicalTrials.gov registry record · NA
Evaluation of Product Performance of a New Silicone Hydrogel Multifocal Contact Lens
A NA study, sponsored by Bausch & Lomb Incorporated.
- Completed
- Registry status
- NA
- Development phase
- 301
- Enrollment target
NCT05660577 is a NA study that has completed, run by Bausch & Lomb Incorporated. The registered enrollment target is 301 participants.
The verdict
NCT05660577, a NA study, has completed, sponsored by Bausch & Lomb Incorporated.
- COMPLETED
- Registry status
- NA
- Development phase
- 301 participants
- Enrollment target
Study Summary
The objective of this study is to evaluate the product performance of a new silicone hydrogel daily disposable multifocal contact lens, the Bausch + Lomb (kalifilcon A) Daily Disposable Multifocal Contact Lens, when worn by current soft contact lens wearers on a daily disposable wear basis
Interventions
- DEVICE new silicone hydrogel daily disposable multifocal contact lens, the Bausch + Lomb (kalifilcon A) Daily Disposable Multifocal Contact Lens
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 301 participants |
| Start Date | 2022-11-07 |
| Est. Completion | 2023-01-16 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05660577
The ClinicalTrials.gov registry entry for NCT05660577 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 301 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bausch & Lomb Incorporated, which has 174 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which new silicone hydrogel daily disposable multifocal contact lens, the Bausch + Lomb (kalifilcon A) Daily Disposable Multifocal Contact Lens is the first listed.
NCT05660577 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05660577 about?
NCT05660577 is a clinical study titled "Evaluation of Product Performance of a New Silicone Hydrogel Multifocal Contact Lens". The objective of this study is to evaluate the product performance of a new silicone hydrogel daily disposable multifocal contact lens, the Bausch + Lomb (kalifilcon A) Daily Disposable Multifocal Contact Lens, when worn by current soft contact lens wearers on a daily disposable wear basis
What is the current status of trial NCT05660577?
This trial is currently completed. It is a NA study. The enrollment target is 301 participants. The study started on 2022-11-07. Estimated completion is 2023-01-16.
What interventions are being tested in trial NCT05660577?
The interventions under investigation include: new silicone hydrogel daily disposable multifocal contact lens, the Bausch + Lomb (kalifilcon A) Daily Disposable Multifocal Contact Lens (DEVICE).
Who is sponsoring clinical trial NCT05660577?
This trial is sponsored by Bausch & Lomb Incorporated, which has 174 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.